Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Edgewise Therapeutics, Inc. (EWTX) had Return on Tangible Equity of -31.42% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-100.16M |
|
-- |
|
-- |
|
$114.36M |
|
$-114.36M |
|
$14.19M |
|
$-100.16M |
|
$-100.16M |
|
$-100.16M |
|
$-100.16M |
|
$-100.16M |
|
$-100.16M |
|
$-114.36M |
|
$-122.14M |
|
63.72M |
|
63.72M |
|
$-1.57 |
|
$-1.57 |
|
| Balance Sheet Financials | |
$327.00M |
|
$10.44M |
|
$13.04M |
|
$340.04M |
|
$16.77M |
|
-- |
|
$4.43M |
|
$21.20M |
|
$318.83M |
|
$318.83M |
|
$318.83M |
|
70.45M |
|
| Cash Flow Statement Financials | |
$-91.95M |
|
$102.89M |
|
$53.17M |
|
$21.99M |
|
$86.10M |
|
$64.10M |
|
$17.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-97.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.42% |
|
|
Return on Tangible Equity |
-31.42% |
-29.46% |
|
-31.42% |
|
$4.53 |
|
$-1.53 |
|
$-1.44 |
|